RF
ALNY icon

Rossby Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History

Rossby Financial’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.9K Sell
136
-7
-5% -$2.11K 0.01% 757
2026
Q1 		$47K Buy
143
+19
+15% +$6.47K 0.01% 747
2025
Q4 		$49.3K Buy
124
+12
+11% +$5.31K 0.02% 544
2025
Q3 		$51.6K Buy
112
+63
+129% +$25.7K 0.02% 528
2025
Q2 		$16K Buy
+49
New +$13.6K 0.01% 698

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rossby Financial's ALNY Position: Q2 2026 in Review

Rossby Financial reduced its Alnylam Pharmaceuticals (ALNY) stake by 4.9% in Q2 2026, selling an estimated $2.11K and leaving 136 shares worth $40.9K. The position accounts for 0.01% of the portfolio, ranked #757.

Rossby Financial first reported a position in ALNY in Q2 2025 and has held it in 5 quarters since. The position peaked at $51.6K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Rossby Financial held 136 shares of Alnylam Pharmaceuticals worth $40.9K as of Q2 2026.
  • Rossby Financial sold 7 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.11K.
  • Alnylam Pharmaceuticals made up 0.01% of Rossby Financial's portfolio in Q2 2026, its #757 holding.
  • Rossby Financial first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Rossby Financial's Alnylam Pharmaceuticals position peaked at $51.6K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.